| 臺大學術典藏 |
2020-02-27T07:43:17Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Lin F.-Y.;WEN-JONE CHEN;Chen S.-C.;Ma M.H.-M.;Ko P.C.-I.;Chen Y.-T.;Yen Z.-S.; Yen Z.-S.; Chen Y.-T.; Ko P.C.-I.; Ma M.H.-M.; Chen S.-C.; WEN-JONE CHEN; Lin F.-Y. |
| 國立臺灣大學 |
2009 |
Cost-Effectiveness of Different Treatments in Patients with Hepatocellular Carcinoma: A Retrospective Study
|
朱柏青; 陳健弘; 王榮德; 黃景祥; CHU, PO-CHING; CHEN, CHIEN-HUNG; WANG, JUNG-DER; HWANG, JING-SHIANG |
| 臺大學術典藏 |
2020-12-25T08:38:43Z |
Cost-effectiveness of drug-eluting stents in patients with stable coronary artery disease
|
Hung C.-S.; Cheng C.-L.; Chao C.-L.; HSIEN-LI KAO; Chen M.-F.; Lin N.-P. |
| 臺大學術典藏 |
2011 |
Cost-effectiveness of drug-eluting stents in patients with stable coronary artery disease
|
Hung C.-S.; Cheng C.-L.; Chao C.-L.; HSIEN-LI KAO; Chen M.-F.; Lin N.-P. |
| 臺大學術典藏 |
2019-07-16T05:34:47Z |
Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective
|
Vilain K.A.;Ming-Chin Yang;Hui Tan E.C.;Wang K.;Li H.;Hsu W.H.;Giugliano R.P.;Cohen D.J.;Magnuson E.A.; Vilain K.A.; MING-CHIN YANG; Hui Tan E.C.; Wang K.; Li H.; Hsu W.H.; Giugliano R.P.; Cohen D.J.; Magnuson E.A. |
| 臺大學術典藏 |
2013 |
Cost-Effectiveness of Expanded Newborn Screening in Texas
|
WEI-CHU CHIE; Hsu, Ching-Fen;Kang, Kun-Tai;Yung-Ling Lee;Wei-Chu Chie; Hsu, Ching-Fen; Kang, Kun-Tai; YUNG-LING LEE |
| 國立臺灣大學 |
2013 |
Cost-Effectiveness of Expanded Newborn Screening in Texas
|
Hsu, Ching-Fen; Kang, Kun-Tai; Lee, Yungling Leo; Chie, Wei-Chu; 季瑋珠; 李永凌 |
| 臺大學術典藏 |
2018-09-10T09:39:39Z |
Cost-effectiveness of expanded newborn screening in Texas
|
Hsu, C.-F. ; Kang, K.-T. ; Leo Lee, Y. ; Chie, W.-C.; WEI-CHU CHIE |
| 臺大學術典藏 |
2022-05-05T09:10:14Z |
Cost-effectiveness of expanded newborn screening in Texas
|
Hsu C.-F.; Kang K.-T.; Leo Lee Y.; WEI-CHU CHIE |
| 國立成功大學 |
2023 |
Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer
|
Yang, S.-C.;Ou, H.-T.;Su, W.-C.;Wang, S.-Y. |
| 國立成功大學 |
2022 |
Cost-effectiveness of First-line Immunotherapy for Non-small Cell Lung Cancer [非小細胞肺癌一線免疫治療的成本效果]
|
Lin, C.-Y.;Yang, S.-C. |
| 中山醫學大學 |
2021 |
Cost-effectiveness of freeze-all policy - A retrospective study based upon the outcome of cumulative live births
|
Chang, JC; Yi, YC; Shen, PS; Guu, HF; Chen, YF; Kung, HF; Chen, LY; Chen, MJ |
| 國立臺灣大學 |
2008 |
Cost-Effectiveness of Gefitinib for First-Line Treatment of Advanced Non- Small Cell Lung Cancer: A Markov Model-Based Analysis
|
劉邦祥; 胡賦強; 王榮德; LIU, PANG-HSIANG; HU, FU-CHANG; WANG, JUNG-DER |
| 嘉南藥理大學 |
2016-05 |
Cost-effectiveness of Gemcitabine Plus Modern Radiotherapy in Locally Advanced Pancreatic Cancer
|
Leung, Henry W. C.; Chan, Agnes L. F.; Muo, Chih-Hsin |
| 國立成功大學 |
2021-01-19 |
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
|
Yang;Chen-Yi;Chen;Ying-Ren;Ou;Huang-Tz;Kuo;Shihchen |
| 國立成功大學 |
2021-12 |
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
|
歐凰姿; Ou, Huang-Tz; Yang, Chen-Yi;Chen, Ying-Ren;Kuo, Shihchen |
| 國立臺灣海洋大學 |
2016 |
Cost-effectiveness of gra nulocyte colony- stimulating factorprophylaxis in chemotherapy-induced febrile neutrop eniaamong breast cancer and Non-Hodgkin’s lymphoma patientsunder Taiwan’s national health insurance system
|
Tsun-Jen Wen; Yu-Wen Wen; Chun-Ru Chien; Shao-Chin Chiang; William Wei-Yuan Hsu; Li-Jiuan Shen; Fei-Yuan Hsiao |
| 臺大學術典藏 |
2018-09-10T18:02:53Z |
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system
|
Wen, T.-J. And Wen, Y.-W. And Chien, C.-R. And Chiang, S.-C. And Hsu, W.W.-Y. And Shen, L.-J. And Hsiao, F.-Y.; LI-JIUAN SHEN |
| 臺大學術典藏 |
2017 |
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system
|
Wen T.-J.;Wen Y.-W.;Chien C.-R.;Chiang S.-C.;Hsu W.W.-Y.;Shen L.-J.;Fei-Yuan Hsiao; Wen T.-J.; Wen Y.-W.; Chien C.-R.; Chiang S.-C.; Hsu W.W.-Y.; Shen L.-J.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2022-09-19T03:16:56Z |
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system
|
Wen T.-J.; Wen Y.-W.; Chien C.-R.; Chiang S.-C.; Hsu W.W.-Y.; Shen L.-J.; FEI-YUAN HSIAO |
| 國立臺灣大學 |
2008 |
Cost-Effectiveness of Hearing Aids in the Hearing-Impaired Elderly: A Probabilistic Approach
|
趙庭寬; 陳秀熙; CHAO, TING-KUANG; CHEN, TONY HSIU-HSI |
| 臺大學術典藏 |
2018-09-10T06:51:12Z |
Cost-effectiveness of hearing aids in the hearing-impaired elderly: A probabilistic approach
|
Chao, T.-K.;Chen, T.H.-H.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2022-04-21T06:51:11Z |
Cost-effectiveness of hearing aids in the hearing-impaired elderly: A probabilistic approach
|
Chao T.-K.; Chen, Tony Hsiu Hsi |
| 義守大學 |
2016-07 |
Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score
|
Yu-Tzu Chang;Jing-Shiang Hwang;Shih-Yuan Hung;Min-SungTsai;Jia-LingWu;Junne-Ming Sung;Jung-DerWang |
| 國立成功大學 |
2016-07 |
Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score
|
Chang, Yu-Tzu; Hwang, Jing-Shiang; Hung, Shih-Yuan; Tsai, Min-Sung; Wu, Jia-Ling; Sung, Junne-Ming; Wang, Jung-Der |
